发明人罗永刚,陈志强,郑宇鹏. "Method for the Synthesis of WGL8B3MDAS
7224-08-0
Imiclopazine
Imiclopazine [INN]
1-(2-(4-(3-(2-Chloro-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl)-3-methyl-2-imidazolidinone
1-(2-(4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazinyl)ethyl)-3-methyl-2-imidazolidinone
Imiclopazina [INN-Spanish]
Imiclopazinum [INN-Latin]
Imiclopazina
Imiclopazinum
UNII-WGL8B3MDAS" [P]. 中国发明专利, 专利号 CN 110297774 B, 授权公告日 2018-09-16.
发明人罗永刚,杨光,何建平. "A Process for Preparing High-Purity WGL8B3MDAS
7224-08-0
Imiclopazine
Imiclopazine [INN]
1-(2-(4-(3-(2-Chloro-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl)-3-methyl-2-imidazolidinone
1-(2-(4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazinyl)ethyl)-3-methyl-2-imidazolidinone
Imiclopazina [INN-Spanish]
Imiclopazinum [INN-Latin]
Imiclopazina
Imiclopazinum
UNII-WGL8B3MDAS" [P]. 中国发明专利, 专利号 CN 117852731 B, 授权公告日 2016-06-08.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2014, 2131, (6), 3369-3390.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2019, 1520, (6), 1045-1070.